MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis
Open Access
- 1 September 1998
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 9 (9) , 1027-1029
- https://doi.org/10.1023/a:1008412009667
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients.Journal of Clinical Oncology, 1997
- Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients.Journal of Clinical Oncology, 1997
- Mediastinal large B‐cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third‐generation regimensBritish Journal of Haematology, 1995
- A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]Blood, 1994
- Mediastinal large-cell lymphoma with sclerosis (MLCLS)British Journal of Cancer, 1994
- Stage II large B-cell lymphoma with sclerosis treated with MACOP-BAnnals of Oncology, 1991
- The F-MACHOP sequential combination chemotherapy regimen in advanced diffuse aggressive lymphomas: Long-term resultsAnnals of Oncology, 1991
- Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients.Journal of Clinical Oncology, 1990
- Mediastinal large‐cell lymphoma of B‐type, with sclerosis: Histopathological and immunohistochemical study of eight casesHistopathology, 1986
- Large cell lymphoma of the mediastinum: a B‐cell tumour of probable thymic originHistopathology, 1986